Do angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) reduce progression to end-stage kidney disease in patients with diabetic kidney disease? Use of ACE inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results